vs
e.l.f. Beauty, Inc.（ELF）与和黄医药（HCM）财务数据对比。点击上方公司名可切换其他公司
e.l.f. Beauty, Inc.的季度营收约是和黄医药的1.8倍（$489.5M vs $270.8M），e.l.f. Beauty, Inc.净利率更高（8.0% vs 0.7%，领先7.3%），e.l.f. Beauty, Inc.同比增速更快（37.8% vs -16.5%），e.l.f. Beauty, Inc.自由现金流更多（$52.8M vs $3.4M）
e.l.f. Beauty是美国知名彩妆品牌，2004年创立，总部位于加利福尼亚州奥克兰。品牌产品线丰富，涵盖沐浴护肤产品、矿物彩妆、专业美妆工具、眼线笔、口红、腮红、睫毛膏等多个品类，产品销往全球18个国家，入驻Target、沃尔玛等主流零售渠道，过半营收来自品牌官网。
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
ELF vs HCM — 直观对比
营收规模更大
ELF
是对方的1.8倍
$270.8M
营收增速更快
ELF
高出54.3%
-16.5%
净利率更高
ELF
高出7.3%
0.7%
自由现金流更多
ELF
多$49.4M
$3.4M
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $489.5M | $270.8M |
| 净利润 | $39.4M | $2.0M |
| 毛利率 | 71.0% | 37.7% |
| 营业利润率 | 13.8% | -13.2% |
| 净利率 | 8.0% | 0.7% |
| 营收同比 | 37.8% | -16.5% |
| 净利润同比 | 128.1% | -83.6% |
| 每股收益（稀释后） | $0.65 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELFHCM
| Q4 25 | $489.5M | $270.8M | ||
| Q3 25 | $343.9M | — | ||
| Q2 25 | $353.7M | $277.7M | ||
| Q1 25 | — | $324.5M | ||
| Q2 24 | — | $305.7M | ||
| Q2 23 | — | $532.9M | ||
| Q2 22 | — | $202.0M |
净利润ELFHCM
| Q4 25 | $39.4M | $2.0M | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $33.3M | $455.0M | ||
| Q1 25 | — | $11.9M | ||
| Q2 24 | — | $25.8M | ||
| Q2 23 | — | $168.6M | ||
| Q2 22 | — | $-162.9M |
毛利率ELFHCM
| Q4 25 | 71.0% | 37.7% | ||
| Q3 25 | 69.4% | — | ||
| Q2 25 | 69.1% | 0.1% | ||
| Q1 25 | — | 48.0% | ||
| Q2 24 | — | 41.1% | ||
| Q2 23 | — | 0.0% | ||
| Q2 22 | — | 0.1% |
营业利润率ELFHCM
| Q4 25 | 13.8% | -13.2% | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 13.8% | -1.3% | ||
| Q1 25 | — | -5.0% | ||
| Q2 24 | — | -9.0% | ||
| Q2 23 | — | 21.0% | ||
| Q2 22 | — | -97.4% |
净利率ELFHCM
| Q4 25 | 8.0% | 0.7% | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 9.4% | 163.8% | ||
| Q1 25 | — | 3.7% | ||
| Q2 24 | — | 8.4% | ||
| Q2 23 | — | 31.6% | ||
| Q2 22 | — | -80.6% |
每股收益（稀释后）ELFHCM
| Q4 25 | $0.65 | $0.00 | ||
| Q3 25 | $0.05 | — | ||
| Q2 25 | $0.58 | $0.52 | ||
| Q1 25 | — | $0.01 | ||
| Q2 24 | — | $0.03 | ||
| Q2 23 | — | $0.19 | ||
| Q2 22 | — | $-0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $196.8M | $1.4B |
| 总债务越低越好 | $816.7M | $93.2M |
| 股东权益账面价值 | $1.2B | $1.2B |
| 总资产 | $2.3B | $1.8B |
| 负债/权益比越低杠杆越低 | 0.70× | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资ELFHCM
| Q4 25 | $196.8M | $1.4B | ||
| Q3 25 | $194.4M | — | ||
| Q2 25 | $170.0M | $1.4B | ||
| Q1 25 | — | $836.1M | ||
| Q2 24 | — | $802.5M | ||
| Q2 23 | — | $856.2M | ||
| Q2 22 | — | $826.2M |
总债务ELFHCM
| Q4 25 | $816.7M | $93.2M | ||
| Q3 25 | $831.6M | — | ||
| Q2 25 | $256.7M | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q2 24 | — | $82.1M | ||
| Q2 23 | — | $40.1M | ||
| Q2 22 | — | $418.0K |
股东权益ELFHCM
| Q4 25 | $1.2B | $1.2B | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $804.9M | $1.2B | ||
| Q1 25 | — | $759.9M | ||
| Q2 24 | — | $740.1M | ||
| Q2 23 | — | $782.0M | ||
| Q2 22 | — | $799.7M |
总资产ELFHCM
| Q4 25 | $2.3B | $1.8B | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $1.3B | $1.8B | ||
| Q1 25 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q2 23 | — | $1.3B | ||
| Q2 22 | — | $1.2B |
负债/权益比ELFHCM
| Q4 25 | 0.70× | 0.08× | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.32× | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q2 23 | — | 0.05× | ||
| Q2 22 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $59.4M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $52.8M | $3.4M |
| 自由现金流率自由现金流/营收 | 10.8% | 1.2% |
| 资本支出强度资本支出/营收 | 1.4% | 1.8% |
| 现金转化率经营现金流/净利润 | 1.51× | 4.21× |
| 过去12个月自由现金流最近4个季度 | — | $-96.2M |
8季度趋势，按日历期对齐
经营现金流ELFHCM
| Q4 25 | $59.4M | $8.2M | ||
| Q3 25 | $23.4M | — | ||
| Q2 25 | $27.2M | $-72.9M | ||
| Q1 25 | — | $40.3M | ||
| Q2 24 | — | $-39.8M | ||
| Q2 23 | — | $226.4M | ||
| Q2 22 | — | $-89.9M |
自由现金流ELFHCM
| Q4 25 | $52.8M | $3.4M | ||
| Q3 25 | $16.6M | — | ||
| Q2 25 | $20.1M | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q2 24 | — | $-49.9M | ||
| Q2 23 | — | $202.0M | ||
| Q2 22 | — | $-105.6M |
自由现金流率ELFHCM
| Q4 25 | 10.8% | 1.2% | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 5.7% | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q2 24 | — | -16.3% | ||
| Q2 23 | — | 37.9% | ||
| Q2 22 | — | -52.3% |
资本支出强度ELFHCM
| Q4 25 | 1.4% | 1.8% | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 2.0% | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q2 24 | — | 3.3% | ||
| Q2 23 | — | 4.6% | ||
| Q2 22 | — | 7.8% |
现金转化率ELFHCM
| Q4 25 | 1.51× | 4.21× | ||
| Q3 25 | 7.82× | — | ||
| Q2 25 | 0.82× | -0.16× | ||
| Q1 25 | — | 3.38× | ||
| Q2 24 | — | -1.54× | ||
| Q2 23 | — | 1.34× | ||
| Q2 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
